Global Recombinant Human Erythropoietin (rhEPO) Supply, Demand and Key Producers, 2023-2029

Page: 95

Published Date: 05 Aug 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Recombinant Human Erythropoietin (rhEPO) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

This report studies the global Recombinant Human Erythropoietin (rhEPO) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Human Erythropoietin (rhEPO), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Erythropoietin (rhEPO) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Human Erythropoietin (rhEPO) total production and demand, 2018-2029, (K Units)
Global Recombinant Human Erythropoietin (rhEPO) total production value, 2018-2029, (USD Million)
Global Recombinant Human Erythropoietin (rhEPO) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin (rhEPO) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human Erythropoietin (rhEPO) domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human Erythropoietin (rhEPO) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin (rhEPO) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin (rhEPO) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Recombinant Human Erythropoietin (rhEPO) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Erythropoietin (rhEPO) market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Human Erythropoietin (rhEPO) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Human Erythropoietin (rhEPO) Market, Segmentation by Type
    ESRD
    Cancer
    HIV
    Wounds and Neural Disease

Global Recombinant Human Erythropoietin (rhEPO) Market, Segmentation by Application
    Hospitals
    Retail Pharmacies

Companies Profiled:
    3SBio
    Shanghai Chemo
    Chengdu Diao
    NCPC Genetech
    Kyowa Hakko Kirin
    Shandong Kexing
    Ahua Pharmaceutical
    Biosidus
    Dragon Pharma

Key Questions Answered
1. How big is the global Recombinant Human Erythropoietin (rhEPO) market?
2. What is the demand of the global Recombinant Human Erythropoietin (rhEPO) market?
3. What is the year over year growth of the global Recombinant Human Erythropoietin (rhEPO) market?
4. What is the production and production value of the global Recombinant Human Erythropoietin (rhEPO) market?
5. Who are the key producers in the global Recombinant Human Erythropoietin (rhEPO) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Recombinant Human Erythropoietin (rhEPO) Introduction
    1.2 World Recombinant Human Erythropoietin (rhEPO) Supply & Forecast
        1.2.1 World Recombinant Human Erythropoietin (rhEPO) Production Value (2018 & 2022 & 2029)
        1.2.2 World Recombinant Human Erythropoietin (rhEPO) Production (2018-2029)
        1.2.3 World Recombinant Human Erythropoietin (rhEPO) Pricing Trends (2018-2029)
    1.3 World Recombinant Human Erythropoietin (rhEPO) Production by Region (Based on Production Site)
        1.3.1 World Recombinant Human Erythropoietin (rhEPO) Production Value by Region (2018-2029)
        1.3.2 World Recombinant Human Erythropoietin (rhEPO) Production by Region (2018-2029)
        1.3.3 World Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2018-2029)
        1.3.4 North America Recombinant Human Erythropoietin (rhEPO) Production (2018-2029)
        1.3.5 Europe Recombinant Human Erythropoietin (rhEPO) Production (2018-2029)
        1.3.6 China Recombinant Human Erythropoietin (rhEPO) Production (2018-2029)
        1.3.7 Japan Recombinant Human Erythropoietin (rhEPO) Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Human Erythropoietin (rhEPO) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Human Erythropoietin (rhEPO) Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Recombinant Human Erythropoietin (rhEPO) Demand (2018-2029)
    2.2 World Recombinant Human Erythropoietin (rhEPO) Consumption by Region
        2.2.1 World Recombinant Human Erythropoietin (rhEPO) Consumption by Region (2018-2023)
        2.2.2 World Recombinant Human Erythropoietin (rhEPO) Consumption Forecast by Region (2024-2029)
    2.3 United States Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029)
    2.4 China Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029)
    2.5 Europe Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029)
    2.6 Japan Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029)
    2.7 South Korea Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029)
    2.8 ASEAN Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029)
    2.9 India Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029)

3 World Recombinant Human Erythropoietin (rhEPO) Manufacturers Competitive Analysis
    3.1 World Recombinant Human Erythropoietin (rhEPO) Production Value by Manufacturer (2018-2023)
    3.2 World Recombinant Human Erythropoietin (rhEPO) Production by Manufacturer (2018-2023)
    3.3 World Recombinant Human Erythropoietin (rhEPO) Average Price by Manufacturer (2018-2023)
    3.4 Recombinant Human Erythropoietin (rhEPO) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Recombinant Human Erythropoietin (rhEPO) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Recombinant Human Erythropoietin (rhEPO) in 2022
        3.5.3 Global Concentration Ratios (CR8) for Recombinant Human Erythropoietin (rhEPO) in 2022
    3.6 Recombinant Human Erythropoietin (rhEPO) Market: Overall Company Footprint Analysis
        3.6.1 Recombinant Human Erythropoietin (rhEPO) Market: Region Footprint
        3.6.2 Recombinant Human Erythropoietin (rhEPO) Market: Company Product Type Footprint
        3.6.3 Recombinant Human Erythropoietin (rhEPO) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Value Comparison
        4.1.1 United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Comparison
        4.2.1 United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Recombinant Human Erythropoietin (rhEPO) Consumption Comparison
        4.3.1 United States VS China: Recombinant Human Erythropoietin (rhEPO) Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Recombinant Human Erythropoietin (rhEPO) Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Recombinant Human Erythropoietin (rhEPO) Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Recombinant Human Erythropoietin (rhEPO) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production (2018-2023)
    4.5 China Based Recombinant Human Erythropoietin (rhEPO) Manufacturers and Market Share
        4.5.1 China Based Recombinant Human Erythropoietin (rhEPO) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value (2018-2023)
        4.5.3 China Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production (2018-2023)
    4.6 Rest of World Based Recombinant Human Erythropoietin (rhEPO) Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Recombinant Human Erythropoietin (rhEPO) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Human Erythropoietin (rhEPO) Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 ESRD
        5.2.2 Cancer
        5.2.3 HIV
        5.2.4 Wounds and Neural Disease
    5.3 Market Segment by Type
        5.3.1 World Recombinant Human Erythropoietin (rhEPO) Production by Type (2018-2029)
        5.3.2 World Recombinant Human Erythropoietin (rhEPO) Production Value by Type (2018-2029)
        5.3.3 World Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Human Erythropoietin (rhEPO) Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Retail Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Recombinant Human Erythropoietin (rhEPO) Production by Application (2018-2029)
        6.3.2 World Recombinant Human Erythropoietin (rhEPO) Production Value by Application (2018-2029)
        6.3.3 World Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2018-2029)

7 Company Profiles
    7.1 3SBio
        7.1.1 3SBio Details
        7.1.2 3SBio Major Business
        7.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.1.4 3SBio Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 3SBio Recent Developments/Updates
        7.1.6 3SBio Competitive Strengths & Weaknesses
    7.2 Shanghai Chemo
        7.2.1 Shanghai Chemo Details
        7.2.2 Shanghai Chemo Major Business
        7.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.2.4 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Shanghai Chemo Recent Developments/Updates
        7.2.6 Shanghai Chemo Competitive Strengths & Weaknesses
    7.3 Chengdu Diao
        7.3.1 Chengdu Diao Details
        7.3.2 Chengdu Diao Major Business
        7.3.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.3.4 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Chengdu Diao Recent Developments/Updates
        7.3.6 Chengdu Diao Competitive Strengths & Weaknesses
    7.4 NCPC Genetech
        7.4.1 NCPC Genetech Details
        7.4.2 NCPC Genetech Major Business
        7.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.4.4 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 NCPC Genetech Recent Developments/Updates
        7.4.6 NCPC Genetech Competitive Strengths & Weaknesses
    7.5 Kyowa Hakko Kirin
        7.5.1 Kyowa Hakko Kirin Details
        7.5.2 Kyowa Hakko Kirin Major Business
        7.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.5.4 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Kyowa Hakko Kirin Recent Developments/Updates
        7.5.6 Kyowa Hakko Kirin Competitive Strengths & Weaknesses
    7.6 Shandong Kexing
        7.6.1 Shandong Kexing Details
        7.6.2 Shandong Kexing Major Business
        7.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.6.4 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Shandong Kexing Recent Developments/Updates
        7.6.6 Shandong Kexing Competitive Strengths & Weaknesses
    7.7 Ahua Pharmaceutical
        7.7.1 Ahua Pharmaceutical Details
        7.7.2 Ahua Pharmaceutical Major Business
        7.7.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.7.4 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Ahua Pharmaceutical Recent Developments/Updates
        7.7.6 Ahua Pharmaceutical Competitive Strengths & Weaknesses
    7.8 Biosidus
        7.8.1 Biosidus Details
        7.8.2 Biosidus Major Business
        7.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.8.4 Biosidus Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Biosidus Recent Developments/Updates
        7.8.6 Biosidus Competitive Strengths & Weaknesses
    7.9 Dragon Pharma
        7.9.1 Dragon Pharma Details
        7.9.2 Dragon Pharma Major Business
        7.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product and Services
        7.9.4 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Dragon Pharma Recent Developments/Updates
        7.9.6 Dragon Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Human Erythropoietin (rhEPO) Industry Chain
    8.2 Recombinant Human Erythropoietin (rhEPO) Upstream Analysis
        8.2.1 Recombinant Human Erythropoietin (rhEPO) Core Raw Materials
        8.2.2 Main Manufacturers of Recombinant Human Erythropoietin (rhEPO) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Recombinant Human Erythropoietin (rhEPO) Production Mode
    8.6 Recombinant Human Erythropoietin (rhEPO) Procurement Model
    8.7 Recombinant Human Erythropoietin (rhEPO) Industry Sales Model and Sales Channels
        8.7.1 Recombinant Human Erythropoietin (rhEPO) Sales Model
        8.7.2 Recombinant Human Erythropoietin (rhEPO) Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Human Erythropoietin (rhEPO) Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Recombinant Human Erythropoietin (rhEPO) Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Recombinant Human Erythropoietin (rhEPO) Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Region (2018-2023)
    Table 5. World Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Region (2024-2029)
    Table 6. World Recombinant Human Erythropoietin (rhEPO) Production by Region (2018-2023) & (K Units)
    Table 7. World Recombinant Human Erythropoietin (rhEPO) Production by Region (2024-2029) & (K Units)
    Table 8. World Recombinant Human Erythropoietin (rhEPO) Production Market Share by Region (2018-2023)
    Table 9. World Recombinant Human Erythropoietin (rhEPO) Production Market Share by Region (2024-2029)
    Table 10. World Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Recombinant Human Erythropoietin (rhEPO) Major Market Trends
    Table 13. World Recombinant Human Erythropoietin (rhEPO) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Recombinant Human Erythropoietin (rhEPO) Consumption by Region (2018-2023) & (K Units)
    Table 15. World Recombinant Human Erythropoietin (rhEPO) Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Recombinant Human Erythropoietin (rhEPO) Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Recombinant Human Erythropoietin (rhEPO) Producers in 2022
    Table 18. World Recombinant Human Erythropoietin (rhEPO) Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Recombinant Human Erythropoietin (rhEPO) Producers in 2022
    Table 20. World Recombinant Human Erythropoietin (rhEPO) Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Recombinant Human Erythropoietin (rhEPO) Company Evaluation Quadrant
    Table 22. World Recombinant Human Erythropoietin (rhEPO) Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Recombinant Human Erythropoietin (rhEPO) Production Site of Key Manufacturer
    Table 24. Recombinant Human Erythropoietin (rhEPO) Market: Company Product Type Footprint
    Table 25. Recombinant Human Erythropoietin (rhEPO) Market: Company Product Application Footprint
    Table 26. Recombinant Human Erythropoietin (rhEPO) Competitive Factors
    Table 27. Recombinant Human Erythropoietin (rhEPO) New Entrant and Capacity Expansion Plans
    Table 28. Recombinant Human Erythropoietin (rhEPO) Mergers & Acquisitions Activity
    Table 29. United States VS China Recombinant Human Erythropoietin (rhEPO) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Recombinant Human Erythropoietin (rhEPO) Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Recombinant Human Erythropoietin (rhEPO) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Recombinant Human Erythropoietin (rhEPO) Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Market Share (2018-2023)
    Table 37. China Based Recombinant Human Erythropoietin (rhEPO) Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Market Share (2018-2023)
    Table 42. Rest of World Based Recombinant Human Erythropoietin (rhEPO) Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Market Share (2018-2023)
    Table 47. World Recombinant Human Erythropoietin (rhEPO) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Recombinant Human Erythropoietin (rhEPO) Production by Type (2018-2023) & (K Units)
    Table 49. World Recombinant Human Erythropoietin (rhEPO) Production by Type (2024-2029) & (K Units)
    Table 50. World Recombinant Human Erythropoietin (rhEPO) Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Recombinant Human Erythropoietin (rhEPO) Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Recombinant Human Erythropoietin (rhEPO) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Recombinant Human Erythropoietin (rhEPO) Production by Application (2018-2023) & (K Units)
    Table 56. World Recombinant Human Erythropoietin (rhEPO) Production by Application (2024-2029) & (K Units)
    Table 57. World Recombinant Human Erythropoietin (rhEPO) Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Recombinant Human Erythropoietin (rhEPO) Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. 3SBio Basic Information, Manufacturing Base and Competitors
    Table 62. 3SBio Major Business
    Table 63. 3SBio Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 64. 3SBio Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. 3SBio Recent Developments/Updates
    Table 66. 3SBio Competitive Strengths & Weaknesses
    Table 67. Shanghai Chemo Basic Information, Manufacturing Base and Competitors
    Table 68. Shanghai Chemo Major Business
    Table 69. Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 70. Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Shanghai Chemo Recent Developments/Updates
    Table 72. Shanghai Chemo Competitive Strengths & Weaknesses
    Table 73. Chengdu Diao Basic Information, Manufacturing Base and Competitors
    Table 74. Chengdu Diao Major Business
    Table 75. Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 76. Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Chengdu Diao Recent Developments/Updates
    Table 78. Chengdu Diao Competitive Strengths & Weaknesses
    Table 79. NCPC Genetech Basic Information, Manufacturing Base and Competitors
    Table 80. NCPC Genetech Major Business
    Table 81. NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 82. NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. NCPC Genetech Recent Developments/Updates
    Table 84. NCPC Genetech Competitive Strengths & Weaknesses
    Table 85. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
    Table 86. Kyowa Hakko Kirin Major Business
    Table 87. Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 88. Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Kyowa Hakko Kirin Recent Developments/Updates
    Table 90. Kyowa Hakko Kirin Competitive Strengths & Weaknesses
    Table 91. Shandong Kexing Basic Information, Manufacturing Base and Competitors
    Table 92. Shandong Kexing Major Business
    Table 93. Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 94. Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Shandong Kexing Recent Developments/Updates
    Table 96. Shandong Kexing Competitive Strengths & Weaknesses
    Table 97. Ahua Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 98. Ahua Pharmaceutical Major Business
    Table 99. Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 100. Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Ahua Pharmaceutical Recent Developments/Updates
    Table 102. Ahua Pharmaceutical Competitive Strengths & Weaknesses
    Table 103. Biosidus Basic Information, Manufacturing Base and Competitors
    Table 104. Biosidus Major Business
    Table 105. Biosidus Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 106. Biosidus Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Biosidus Recent Developments/Updates
    Table 108. Dragon Pharma Basic Information, Manufacturing Base and Competitors
    Table 109. Dragon Pharma Major Business
    Table 110. Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product and Services
    Table 111. Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 112. Global Key Players of Recombinant Human Erythropoietin (rhEPO) Upstream (Raw Materials)
    Table 113. Recombinant Human Erythropoietin (rhEPO) Typical Customers
    Table 114. Recombinant Human Erythropoietin (rhEPO) Typical Distributors
List of Figure
    Figure 1. Recombinant Human Erythropoietin (rhEPO) Picture
    Figure 2. World Recombinant Human Erythropoietin (rhEPO) Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Human Erythropoietin (rhEPO) Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Recombinant Human Erythropoietin (rhEPO) Production (2018-2029) & (K Units)
    Figure 5. World Recombinant Human Erythropoietin (rhEPO) Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Region (2018-2029)
    Figure 7. World Recombinant Human Erythropoietin (rhEPO) Production Market Share by Region (2018-2029)
    Figure 8. North America Recombinant Human Erythropoietin (rhEPO) Production (2018-2029) & (K Units)
    Figure 9. Europe Recombinant Human Erythropoietin (rhEPO) Production (2018-2029) & (K Units)
    Figure 10. China Recombinant Human Erythropoietin (rhEPO) Production (2018-2029) & (K Units)
    Figure 11. Japan Recombinant Human Erythropoietin (rhEPO) Production (2018-2029) & (K Units)
    Figure 12. Recombinant Human Erythropoietin (rhEPO) Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 15. World Recombinant Human Erythropoietin (rhEPO) Consumption Market Share by Region (2018-2029)
    Figure 16. United States Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 17. China Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 18. Europe Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 19. Japan Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 22. India Recombinant Human Erythropoietin (rhEPO) Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Recombinant Human Erythropoietin (rhEPO) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Erythropoietin (rhEPO) Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Erythropoietin (rhEPO) Markets in 2022
    Figure 26. United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Recombinant Human Erythropoietin (rhEPO) Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Human Erythropoietin (rhEPO) Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Market Share 2022
    Figure 30. China Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Market Share 2022
    Figure 32. World Recombinant Human Erythropoietin (rhEPO) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Type in 2022
    Figure 34. ESRD
    Figure 35. Cancer
    Figure 36. HIV
    Figure 37. Wounds and Neural Disease
    Figure 38. World Recombinant Human Erythropoietin (rhEPO) Production Market Share by Type (2018-2029)
    Figure 39. World Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Type (2018-2029)
    Figure 40. World Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2018-2029) & (USD/Unit)
    Figure 41. World Recombinant Human Erythropoietin (rhEPO) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Application in 2022
    Figure 43. Hospitals
    Figure 44. Retail Pharmacies
    Figure 45. World Recombinant Human Erythropoietin (rhEPO) Production Market Share by Application (2018-2029)
    Figure 46. World Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Application (2018-2029)
    Figure 47. World Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2018-2029) & (USD/Unit)
    Figure 48. Recombinant Human Erythropoietin (rhEPO) Industry Chain
    Figure 49. Recombinant Human Erythropoietin (rhEPO) Procurement Model
    Figure 50. Recombinant Human Erythropoietin (rhEPO) Sales Model
    Figure 51. Recombinant Human Erythropoietin (rhEPO) Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma

Related Reports

Global Recombinant Human Erythropoietin (rhEPO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Recombinant Human Erythropoietin (rhEPO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 05 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Human Erythropoietin (rhEPO) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Recombinant Human Erythropoietin (rhEPO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Recombinant Human Erythropoietin (rhEPO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Human Erythropoietin (rhEPO) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Recombinant Human Erythropoietin (rhEPO)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>